113 related articles for article (PubMed ID: 21868539)
1. CT and MR imaging of the adrenal glands in cortisol-secreting tumors.
Lumachi F; Marchesi P; Miotto D; Motta R
Anticancer Res; 2011 Sep; 31(9):2923-6. PubMed ID: 21868539
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of the adrenal gland.
Boland GW; Lee MJ
Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177
[TBL] [Abstract][Full Text] [Related]
6. Adrenal neoplasms.
Low G; Dhliwayo H; Lomas DJ
Clin Radiol; 2012 Oct; 67(10):988-1000. PubMed ID: 22486993
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
[TBL] [Abstract][Full Text] [Related]
8. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
9. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
Park BK; Kim CK; Kim B; Lee JH
Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
[TBL] [Abstract][Full Text] [Related]
10. Importance of adrenal incidentaloma in patients with a history of malignancy.
Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
[TBL] [Abstract][Full Text] [Related]
11. [Imaging of adrenal incidentalomas].
Hoeffel C; Clément A; Oudjit A; Hazebroucq V; Augui J; Legmann P; Luton JP; Bonnin A
J Radiol; 1998 Sep; 79(9):837-48. PubMed ID: 9791763
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
13. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
14. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
[TBL] [Abstract][Full Text] [Related]
15. Chemical Shift MR Imaging of the Adrenal Gland: Principles, Pitfalls, and Applications.
Adam SZ; Nikolaidis P; Horowitz JM; Gabriel H; Hammond NA; Patel T; Yaghmai V; Miller FH
Radiographics; 2016; 36(2):414-32. PubMed ID: 26849154
[TBL] [Abstract][Full Text] [Related]
16. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW
J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
[TBL] [Abstract][Full Text] [Related]
18. [Imaging of adrenal tumors].
Otal P; Grenier N; Chabbert V; Basseau F; Joffre F
J Radiol; 2002 Jun; 83(6 Pt 2):897-09, discussion 911-2. PubMed ID: 12218864
[TBL] [Abstract][Full Text] [Related]
19. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
20. [Imaging of tumours of the adrenal gland].
Heinz-Peer G; Happel B; Prager G; Niederle B
Wien Klin Wochenschr; 2003; 115 Suppl 2():65-70. PubMed ID: 15518149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
